Thursday, November 21, 2013

Fetal Stem Cells To Treat ALS


Neuralstem’s treatment for amyotrophic lateral sclerosis (ALS), now into Phase 2 clinical trials, is getting more enthusiastic attention.
Ted Harada, diagnosed with the disease in 2010, has been a walking advertisement for their treatment after two surgeries that he underwent as part of the Phase 1 clinical trials at Emory University. The surgeries restored his balance and ability to walk.
Continue reading at Forbes...